drugset / Trial / NCT02063386
AZD1722 Open Label, Absorption Distribution Metabolism and Excretion Study
Non-randomizedSingle-groupOpen-labelBasic science
Summary
To assess the absorption, distribution, metabolism and excretion of a single dose of 14C labelled AZD1722 in order to define the rates and routes of elimination of AZD1722 and if formed, metabolites.
Timeline
- Start
- 2014-04
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenapanor | Small molecule | 15 mg | Oral |
Indications
No indication recorded.